Cobus Loots, CEO of Pan African Resources, on delivering sector-leading returns for shareholders. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,788.50
Bid: 1,788.50
Ask: 1,789.00
Change: 0.00 (0.00%)
Spread: 0.50 (0.028%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 1,788.50
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

DIRECTOR DEALINGS: Glaxo Executives Acquire Shares

Wed, 12th Feb 2014 16:12

LONDON (Alliance News) - Glaxosmithkline PLC Wednesday said senior executives, including Chief Executive Andrew Witty and Chief Financial Officer Simon Dingermans, acquired shares under the company share reward plan at a price of 1631.63 pence Monday.

Details are as follows.

Sir Andrew Witty

Acquisition of 8 Ordinary Shares under the personal contribution element of the Plan

 

 

 

Acquisition of 8 Ordinary Shares under the matching element of the Plan (Company contribution)

 

 

Mr S Dingemans

Acquisition of 8 Ordinary Shares under the personal contribution element of the Plan

 

 

 

Acquisition of 8 Ordinary Shares under the matching element of the Plan (Company contribution)

 

 

Mr S M Bicknell

Acquisition of 8 Ordinary Shares under the personal contribution element of the Plan

 

 

 

Acquisition of 8 Ordinary Shares under the matching element of the Plan (Company contribution)

 

 

Mr R G Connor

Acquisition of 8 Ordinary Shares under the personal contribution element of the Plan

 

 

 

Acquisition of 8 Ordinary Shares under the matching element of the Plan (Company contribution)

 

 

Mr D S Redfern

Acquisition of 8 Ordinary Shares under the personal contribution element of the Plan

 

 

 

Acquisition of 8 Ordinary Shares under the matching element of the Plan (Company contribution)

 

 

Ms C Thomas

Acquisition of 8 Ordinary Shares under the personal contribution element of the Plan

 

 

 

Acquisition of 8 Ordinary Shares under the matching element of the Plan (Company contribution)

 

Mr P C Thomson

Acquisition of 7 Ordinary Shares under the personal contribution element of the Plan

 

Acquisition of 7 Ordinary Shares under the matching element of the Plan (Company contribution)

 

 

 

Dr P J T Vallance

 

Acquisition of  7 Ordinary Shares under the personal contribution element of the Plan

 

 

 

Acquisition of  7 Ordinary Shares under the matching element of the Plan (Company contribution)

 

 

Ms E Walmsley

Acquisition of 8 Ordinary Shares under the personal contribution element of the Plan

 

Acquisition of 8 Ordinary Shares under the matching element of the Plan (Company contribution)

 

 

Mrs V A Whyte

Acquisition of 8  Ordinary Shares under the personal contribution element of the Plan

 

 

 

Acquisition of 8 Ordinary Shares under the matching element of the Plan (Company contribution



Shares in the healthcare company were up 0.7% at 1,654.50 pence Wednesday.

By Arvind Bhunjun; arvindbhunjun@alliancenews.com; @ArvindBhunjun

Copyright © 2014 Alliance News Limited. All Rights Reserved.

More News
6 Feb 2024 07:23

GSK reports positive myeloma trial results, progresses vaccine applications

(Sharecast News) - GSK reported progress in its trial of a myeloma treatment on Tuesday, as well as regulatory progress around its shingles vaccine in China and its RSV vaccine in the United States.

Read more
1 Feb 2024 09:27

TOP NEWS: GSK maintains "vigorous" defence after settling Zantac case

(Alliance News) - GSK PLC on Thursday insisted upon its scientific integrity, after reaching another settlement in ongoing litigation over alleged links between its heartburn drug and cancer.

Read more
1 Feb 2024 09:11

GSK settles Zantac case in California without admitting liability

(Sharecast News) - GSK announced on Thursday that it had reached a confidential settlement to effectively resolve the legal case over Zantac filed in a California state court.

Read more
1 Feb 2024 09:03

LONDON BROKER RATINGS: Barclays cuts Next; JPMorgan raises easyJet

(Alliance News) - The following London-listed shares received analyst recommendations Thursday morning:

Read more
1 Feb 2024 07:42

LONDON BRIEFING: Shell profit falls; announces USD3.5 billion buyback

(Alliance News) - Stocks in London are set to follow New York into the red, after the US Federal Reserve quashed hopes of a March cut to interest rates and ahead of the Bank of England interest rate decision.

Read more
31 Jan 2024 17:05

LONDON MARKET CLOSE: Stocks mixed hours before expected US Fed hold

(Alliance News) - Stock prices in London closed mixed on Wednesday in a trade-thinned day ahead of the US Federal Reserve interest rate decision this evening.

Read more
31 Jan 2024 15:49

London close: Stocks mixed ahead of US Fed, BoE decisions

(Sharecast News) - London's financial markets finished with mixed performance on Wednesday, with investors closing their wallets ahead of rate announcements from both the US Federal Reserve and the Bank of England.

Read more
31 Jan 2024 12:05

LONDON MARKET MIDDAY: FTSE 100 flat ahead of Federal Reserve decision

(Alliance News) - The FTSE 100 in London was flat heading into Wednesday afternoon, as the US Federal Reserve's latest interest rate decision edges closer, keeping equity market enthusiasm to a minimum.

Read more
31 Jan 2024 09:13

TOP NEWS: GSK profit up on Arexvy boost in 2023 but total payout down

(Alliance News) - GSK PLC reported an increase in profit and revenue for 2023 as revenue for HIV medicine had stable growth, amid optimism in the company's outlook.

Read more
31 Jan 2024 08:55

LONDON MARKET OPEN: Stocks lack direction ahead of Fed, BoE

(Alliance News) - Stock prices in London lacked direction at the open on Wednesday, as investors nervously look ahead to interest rate decisions from the US Federal Reserve and Bank of England.

Read more
31 Jan 2024 07:46

LONDON BRIEFING: Stocks called up; GSK revenue and profit up

(Alliance News) - Stocks in London are called to open higher, as markets share of nerves around the next set of interest rate decisions.

Read more
29 Jan 2024 08:51

GSK seeks expanded use of RSV vaccine in EU, wins approval for Omjjara

(Alliance News) - GSK PLC on Monday celebrated regulatory progress for two of its products in the EU.

Read more
29 Jan 2024 07:43

LONDON BRIEFING: Superdry looks at saving costs; Ferrexpo loses case

(Alliance News) - Stocks in London are expected to start the week on a cautious note, as investors nervously look ahead to two key interest rate decisions.

Read more
29 Jan 2024 07:07

GSK gets EU approval to sell blood cancer treatment Omijara

(Sharecast News) - Biopharma giant GSK has been given the green light by European regulators to sell Omjjara, its treatment for patients with a rare type of blood cancer.

Read more
26 Jan 2024 10:47

Citi hikes target price for GSK but stays 'neutral'

(Sharecast News) - Shares in biopharma giant GSK were rising on Friday, helped by forecast upgrades from Citi, which raised its target price on the stock from 1,535p to 1,700p.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.